bioAffinity Technologies, Inc. (BIAF) is an innovative biotechnology firm based in San Antonio, Texas, focused on advancing non-invasive diagnostic solutions and targeted therapies for cancer. The company's proprietary technology aims to improve early detection and treatment outcomes, addressing critical needs in oncology. With a commitment to enhancing patient care through cutting-edge research and development, bioAffinity is poised to make significant strides in the fight against cancer.